Patents by Inventor Wenlin Shao

Wenlin Shao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER
    Publication number: 20180289670
    Abstract: The invention relates to a combination comprising the N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)-ethyl]-amino]methyl]phenyl]-2E-2-propenamide; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination.
    Type: Application
    Filed: June 12, 2018
    Publication date: October 11, 2018
    Inventors: Peter Wisdom Atadja, Wenlin Shao, Kapil N. Bhalla
  • COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER
    Publication number: 20180071251
    Abstract: The invention relates to a combination comprising the N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)-ethyl]-amino]methyl]phenyl]-2E-2-propenamide; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination.
    Type: Application
    Filed: November 14, 2017
    Publication date: March 15, 2018
    Inventors: Peter Wisdom Atadja, Wenlin Shao, Kapil N. Bhalla
  • COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER
    Publication number: 20170246147
    Abstract: The invention relates to a combination comprising the N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)-ethyl]-amino]methyl]phenyl]-2E-2-propenamide; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination.
    Type: Application
    Filed: May 17, 2017
    Publication date: August 31, 2017
    Applicant: Novartis AG
    Inventors: Peter Wisdom Atadja, Wenlin Shao, Kapil N. Bhalla
  • COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER
    Publication number: 20170027909
    Abstract: The invention relates to a combination comprising the N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)-ethyl]-amino]methyl]phenyl]-2E-2-propenamide; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination.
    Type: Application
    Filed: July 28, 2016
    Publication date: February 2, 2017
    Applicant: Novartis AG
    Inventors: Peter Wisdom Atadja, Wenlin Shao, Kapil N. Bhalla
  • COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER
    Publication number: 20150094274
    Abstract: The invention relates to a combination comprising the N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)-ethyl]-amino]methyl]phenyl]-2E-2-propenamide; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination.
    Type: Application
    Filed: December 8, 2014
    Publication date: April 2, 2015
    Inventors: Peter Wisdom Atadja, Wenlin Shao, Kapil N. Bhalla
  • COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER
    Publication number: 20130029927
    Abstract: The invention relates to a combination comprising the N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)-ethyl]-amino]methyl]phenyl]-2E-2-propenamide; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination.
    Type: Application
    Filed: July 25, 2012
    Publication date: January 31, 2013
    Inventors: Peter Wisdom Atadja, Wenlin Shao, Kapil N. Bhalla
  • USE OF HDAC INHIBITORS FOR THE TREATMENT OF BONE DESTRUCTION
    Publication number: 20120029047
    Abstract: The present invention relates to the use of HDAC inhibitors for the treatment of bone destruction caused by cancer, inflammatory diseases and osteoporosis.
    Type: Application
    Filed: August 2, 2011
    Publication date: February 2, 2012
    Inventors: Peter Wisdom Atadja, Joseph Daniel Growney, Wenlin Shao
  • USE OF HDAC INHIBITORS FOR THE TREATMENT OF LYMPHOMAS
    Publication number: 20110124701
    Abstract: The present invention relates to the use of an HDAC inhibitor, especially an HDAC inhibitor of formula (I): wherein the radicals and symbols have the meanings as defined in the specification, for the preparation of a medicament for the treatment of lymphoproliferative diseases, in particular, cutaneous T-cell lymphomas.
    Type: Application
    Filed: November 29, 2010
    Publication date: May 26, 2011
    Applicant: NOVARTIS AG
    Inventors: Peter Wisdom Atadja, Wenlin Shao
  • Use of HDAC Inhibitors for the Treatment of Bone Destruction
    Publication number: 20100179208
    Abstract: The present invention relates to the use of HDAC inhibitors for the treatment of bone destruction caused by cancer, inflammatory diseases and osteoporosis.
    Type: Application
    Filed: May 28, 2008
    Publication date: July 15, 2010
    Applicant: NOVARTIS AG
    Inventors: Peter Wisdom Atadja, Joseph Daniel Growney, Wenlin Shao
  • COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER
    Publication number: 20100069458
    Abstract: The invention relates to a combination comprising the N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)-ethyl]-amino]methyl]phenyl]-2E-2-propenamide; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination.
    Type: Application
    Filed: February 13, 2008
    Publication date: March 18, 2010
    Inventors: Peter Wisdom Atadja, Wenlin Shao, Kapil N. Bhalla
  • USE OF HDAC INHIBITORS FOR THE TREATMENT OF LYMPHOMAS
    Publication number: 20090281159
    Abstract: The present invention relates to the use of an HDAC inhibitor, especially an HDAC inhibitor of formula (I): wherein the radicals and symbols have the meanings as defined in the specification, for the preparation of a medicament for the treatment of lymphoproliferative diseases, in particular, cutaneous T-cell lymphomas.
    Type: Application
    Filed: June 26, 2007
    Publication date: November 12, 2009
    Applicant: NOVARTIS AG
    Inventors: Peter Wisdom Atadja, Wenlin Shao